|MKEA -- France Stock|| |
EUR 2.87 0.045 1.54%
CFO and VP of Fin.
Mr. Eric Cohen serves as Vice President of Finance at Mauna Kea Technologies SA. Prior to joining the Company, he served as Chief Financial Officer of Biocortech and as Deputy General Manager and Chief Financial Officer of publiclyheld Hybrigenics. Prior to joining Hybrigenics, he was Finance Director of Teva Pharmaceutical in France. He was also previously Chief Financial Officer of Radio BFM
33 1 48 24 03 45 http://www.maunakeatech.com
Cohen holds an MBA from University of London and a Masters in Finance from Dauphine University in Paris.
Eric Cohen Latest Insider Activity
The company has return on total asset (ROA)
of (35.99) %
which means that it has lost $35.99 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (123.6) %
meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.82 M in total debt with debt to equity ratio (D/E) of 83.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Mauna Kea Technologies SA has Current Ratio of 3.35 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Mauna Kea Technologies SA, a medical device company, develops and sells endomicroscopy and optical biopsy for the diagnosis and treatment of cancer and other diseases. The company was founded in 2000 and is headquartered in Paris, France. Mauna Kea operates under Medical Equipment classification in France and traded on Paris Stock Exchange.Mauna Kea Technologies SA (MKEA) is traded on Paris Stock Exchange in France. It is located in 9, rue d'Enghien and employs 81 people.
Mauna Kea Technologies Leadership Team
|Olivier Regnard, CEO|
|Bertrand Talhouet, Director|
|Eric Cohen, CFO, MBA|
|Gilles Brisson, Chairman|
|Alexandre Loiseau, CEO, Ph.D|
|Guillaume Bailliard, President, MBA|
|Christopher McFadden, Director, CFA|
|Francois Lacombe, Executive, Ph.D|
|Christopher Tihansky, President, MBA|
|JeanLuc Boulnois, Director, MBA|
|Bruno Villaret, President|
|Joseph DeVivo, Director|
|Christophe Bailleul, President, MBA|
|Agnes Rouffiac, Director|
|Veronique Dentan, Director|
|Sebastien Cadet, Director|
|Sacha Loiseau, CEO, Ph.D|
|Molly ONeill, Director|
|Pierre Forest, COO|
|John Soto, COO|
|Marie Meynadier, Director|
Stock Performance Indicators